India's Health Ministry seeking to speed approvals of vaccines

10 October 2019

Teaming up with the Drug Controller General of India (DCGI), the Indian Council of Medical Research and the Department of Biotechnology (DBT), India’s Health Ministry is looking to halve the time taken to get vaccines approved from the 15 years it normally takes if one follows strict procedures.

The Health Ministry has been looking to bring in faster regulatory reforms and speedy approvals. Sources said the Ministry is also exploring options to do away with animal testing.

With researchers from different countries along with regulators including the US Food and Drug Administration, European Medicines Agency, Medicines and Healthcare products Regulatory Agency and experts from the World Health Organization set to gather in India next month, talks will revolve around the broad guidelines of Controlled Human Infection Model (CHIM) studies.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK